千红制药(002550)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002550 千红制药

已收盘 07-11 15:00:00

{"stockData":{"symbol":"002550","market":"SZ","secType":"STK","nameCN":"千红制药","latestPrice":9.45,"timestamp":1752217383000,"preClose":9.51,"halted":0,"volume":131440994,"delay":0,"changeRate":-0.0063,"floatShares":958000000,"shares":1280000000,"eps":0.3227,"marketStatus":"已收盘","change":-0.06,"latestTime":"07-11 15:00:00","open":9.39,"high":9.74,"low":9.33,"amount":1249000000,"amplitude":0.0431,"askPrice":9.46,"askSize":631,"bidPrice":9.45,"bidSize":1019,"shortable":0,"etf":0,"ttmEps":0.3227,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752456600000},"marketStatusCode":5,"adr":0,"adjPreClose":9.51,"symbolType":"stock","openAndCloseTimeList":[[1752197400000,1752204600000],[1752210000000,1752217200000]],"highLimit":10.46,"lowLimit":8.56,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1279800000,"isCdr":false,"pbRate":4.54,"roa":"--","peRate":29.284165,"roe":"6.2%","epsLYR":0.28,"committee":0.335122,"marketValue":12094000000,"turnoverRate":0.1372,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2025-07-14。","floatMarketCap":9051000000},"requestUrl":"/m/hq/s/002550","defaultTab":"news","newsList":[{"id":"2550519169","title":"千红制药股价小幅下跌 肝素产业链项目投产引关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2550519169","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550519169?lang=zh_cn&edition=full","pubTime":"2025-07-11 21:54","pubTimestamp":1752242053,"startTime":"0","endTime":"0","summary":"截至2025年7月11日15时，千红制药股价报9.45元，较前一交易日下跌0.63%。千红制药属于化学制药板块，主营业务为肝素原料药及制剂的研发、生产和销售。公司是国内少数覆盖肝素全产业链的企业，产品包括标准肝素钠注射液等肝素制剂。7月8日，千红制药与牧原集团合资建设的河南千牧生物制药项目正式投产。同日，公司与荷兰CTH公司签署了肠衣项目战略合作协议。2025年7月11日，千红制药主力资金净流出1.51亿元，占流通市值的1.67%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/11215451644647.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["002550","BK0239"],"gpt_icon":0},{"id":"2550560699","title":"千红制药：河南千牧生物制药项目已经顺利投产","url":"https://stock-news.laohu8.com/highlight/detail?id=2550560699","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550560699?lang=zh_cn&edition=full","pubTime":"2025-07-10 11:33","pubTimestamp":1752118392,"startTime":"0","endTime":"0","summary":"证券之星消息，千红制药(002550)07月10日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，您好。请问千牧生物制药项目是否于2025年6月底正式投产了？千红制药回复：投资者，您好，河南千牧生物制药项目已经顺利投产，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071000014519.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002550","BK0239"],"gpt_icon":0},{"id":"2550699523","title":"千红制药：公司的创新药物均具有自主知识产权","url":"https://stock-news.laohu8.com/highlight/detail?id=2550699523","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550699523?lang=zh_cn&edition=full","pubTime":"2025-07-10 11:33","pubTimestamp":1752118383,"startTime":"0","endTime":"0","summary":"证券之星消息，千红制药(002550)07月10日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘：请问公司的4款创新药有专利权吗？千红制药回复：投资者，您好，公司的创新药物均具有自主知识产权，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071000014509.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK1161","002550","06978","159992","BK0239"],"gpt_icon":0},{"id":"2550693984","title":"异动快报：千红制药（002550）7月10日10点10分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2550693984","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550693984?lang=zh_cn&edition=full","pubTime":"2025-07-10 10:15","pubTimestamp":1752113724,"startTime":"0","endTime":"0","summary":"证券之星7月10日盘中消息，10点10分千红制药触及涨停板。目前价格9.78，上涨10.01%。其所属行业化学制药目前上涨。领涨股为誉衡药业。该股为精准医疗，创新药，化学原料药概念热股，当日精准医疗概念上涨2.02%，创新药概念上涨1.84%，化学原料药概念上涨1.73%。7月9日的资金流向数据方面，主力资金净流出3436.13万元，占总成交额5.95%，游资资金净流出422.12万元，占总成交额0.73%，散户资金净流入3858.25万元，占总成交额6.68%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071000009951.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002550","BK0239"],"gpt_icon":0},{"id":"2550650754","title":"千红制药股价下跌1.55% 肝素产业链布局迎新进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2550650754","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550650754?lang=zh_cn&edition=full","pubTime":"2025-07-10 03:02","pubTimestamp":1752087770,"startTime":"0","endTime":"0","summary":"截至2025年7月9日收盘，千红制药股价报8.89元，较前一交易日下跌1.55%，成交额5.77亿元，换手率6.76%。7月8日，千红制药与牧原集团合资建设的河南千牧生物制药项目正式投产，同时与荷兰CTH公司签约肠衣项目。该项目依托牧原集团的生猪资源优势，旨在打造全球领先的猪副产品综合利用及生物制药基地，进一步强化公司在肝素产业链的布局。7月9日，千红制药主力资金净流出3436.13万元，占流通市值的0.4%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/10030251596143.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["002550","BK0239"],"gpt_icon":0},{"id":"2548903047","title":"熊去氧胆酸概念盘中拉升，千红制药涨1.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548903047","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548903047?lang=zh_cn&edition=full","pubTime":"2025-07-01 09:37","pubTimestamp":1751333862,"startTime":"0","endTime":"0","summary":"07月01日，熊去氧胆酸概念盘中拉升，截至09点37分，熊去氧胆酸概念整体指数上涨0.51%，报1201.720点。从个股上来看，该概念的成分股中，千红制药涨1.67%，海辰药业、科伦药业、宣泰医药涨幅居前。从资金上来看，截止发稿，熊去氧胆酸概念主力净流入为-2143.61万，其中科伦药业受到资金热捧，主力净流入646.67万；拉长时间线来看，该板块近20日主力资金净流入-31.38亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701093742a4c7ba8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701093742a4c7ba8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["002550","688247","BK0239"],"gpt_icon":0},{"id":"2546297473","title":"6月25日千红制药现1笔大宗交易 机构净卖出2755.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546297473","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546297473?lang=zh_cn&edition=full","pubTime":"2025-06-25 17:08","pubTimestamp":1750842495,"startTime":"0","endTime":"0","summary":"证券之星消息，6月25日千红制药发生大宗交易，交易数据如下：大宗交易成交价格8.61元，成交320万股，成交金额2755.2万元，买方营业部为华泰证券股份有限公司常州和平北路证券营业部，卖方营业部为机构专用。近三个月该股共发生3笔大宗交易，合计成交22.0万手。截至2025年6月25日收盘，千红制药报收于8.61元，下跌3.48%，换手率9.95%，成交量95.32万手，成交额8.26亿元。该股最近90天内共有3家机构给出评级，买入评级2家，增持评级1家。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062500027384.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002550","BK0239"],"gpt_icon":0},{"id":"2544197424","title":"千红制药：公司目前有4只创新药物正处于二期临床、即将进入三期临床的阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2544197424","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544197424?lang=zh_cn&edition=full","pubTime":"2025-06-20 08:40","pubTimestamp":1750380023,"startTime":"0","endTime":"0","summary":"证券之星消息，千红制药(002550)06月19日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘：请问公司有正在三期临床的1类创新药吗？有的话是治疗哪些病症的？望告之！千红制药回复：投资者，您好，公司目前有4只创新药物正处于二期临床、即将进入三期临床的阶段，具体创新药物研究进展敬请关注公司定期报告及相关公告，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062000004501.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002550","159992","BK1574","06978","BK0239","BK1161"],"gpt_icon":0},{"id":"2544166756","title":"千红制药(002550.SZ)获股东王轲增持0.75%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2544166756","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544166756?lang=zh_cn&edition=full","pubTime":"2025-06-19 19:21","pubTimestamp":1750332068,"startTime":"0","endTime":"0","summary":"智通财经APP讯，千红制药(002550.SZ)公告，公司实际控制人王耀方先生的一致行动人王轲先生已于2025年6月通过大宗交易方式增持公司股份960万股，占公司总股本比例0.75%。同时，王轲先生计划自本公告披露之日起6个月内通过大宗交易方式继续增持公司股份，本次计划增持的股份总数量不少于1240万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1307396.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","002550"],"gpt_icon":0},{"id":"2544929486","title":"6月18日千红制药跌5.95%，景顺长城量化小盘股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2544929486","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544929486?lang=zh_cn&edition=full","pubTime":"2025-06-18 16:26","pubTimestamp":1750235205,"startTime":"0","endTime":"0","summary":"证券之星消息，6月18日千红制药跌5.95%，收盘报8.54元，换手率14.95%，成交量143.2万手，成交额12.07亿元。重仓千红制药的公募基金请见下表：该股最近90天内共有3家机构给出评级，买入评级2家，增持评级1家。根据2025基金Q1季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为景顺长城基金的景顺长城量化小盘股票A。景顺长城量化小盘股票A目前规模为2.33亿元，最新净值1.4144，较上一交易日下跌0.04%，近一年上涨27.02%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061800024379.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002550"],"gpt_icon":0},{"id":"2544914594","title":"千红制药：公司近日参加了欧洲血液病学会年会并在会议上发表了原创一类创新药物初步结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2544914594","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544914594?lang=zh_cn&edition=full","pubTime":"2025-06-18 08:40","pubTimestamp":1750207228,"startTime":"0","endTime":"0","summary":"证券之星消息，千红制药(002550)06月17日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司于2025年6月14日在欧洲血液病学会年会（EHA）展示的最新成果情况如何？成果能否给公司带来收益？千红制药回复：投资者，您好，公司近日参加了欧洲血液病学会年会（EHA）并在会议上发表了原创一类创新药物QHRD107Ⅱa期研究的初步结果，具体数据烦请详询EHA官网文件，感谢您的关注与支持。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061800005262.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002550","159992","BK1574","06978","BK0239","BK1161"],"gpt_icon":0},{"id":"2544149119","title":"千红制药：公司暂无与脑再生科技的业务合作关系","url":"https://stock-news.laohu8.com/highlight/detail?id=2544149119","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544149119?lang=zh_cn&edition=full","pubTime":"2025-06-18 08:40","pubTimestamp":1750207203,"startTime":"0","endTime":"0","summary":"金融界6月18日消息，有投资者在互动平台向千红制药提问：公司与脑再生科技有业务合作关系吗？公司回答表示：投资者，您好，公司暂无此项业务，感谢您的关注。\n\n\r\n            责任编辑：磐石","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/18084051133514.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["002550","BK4539","BK4007","BK0239"],"gpt_icon":0},{"id":"2543627449","title":"6月16日千红制药（002550）龙虎榜数据：游资章盟主上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2543627449","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543627449?lang=zh_cn&edition=full","pubTime":"2025-06-16 17:14","pubTimestamp":1750065271,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年6月16日公布的交易公开信息显示，千红制药因日跌幅偏离值达到7%的前5只证券登上龙虎榜。此次是近5个交易日内第2次上榜。截至2025年6月16日收盘，千红制药报收于9.43元，下跌7.82%，换手率22.02%，成交量210.93万手，成交额19.85亿元。从龙虎榜公布的当日买卖数据来看，北向资金合计净卖出7373.35万元。章盟主等知名游资榜上有名。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061600021246.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002550"],"gpt_icon":0},{"id":"2543294376","title":"6月16日千红制药跌7.82%，景顺长城量化小盘股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2543294376","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543294376?lang=zh_cn&edition=full","pubTime":"2025-06-16 16:26","pubTimestamp":1750062362,"startTime":"0","endTime":"0","summary":"证券之星消息，6月16日千红制药跌7.82%，收盘报9.43元，换手率22.02%，成交量210.93万手，成交额19.85亿元。重仓千红制药的公募基金请见下表：该股最近90天内共有3家机构给出评级，买入评级2家，增持评级1家。根据2025基金Q1季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为景顺长城基金的景顺长城量化小盘股票A。景顺长城量化小盘股票A目前规模为2.33亿元，最新净值1.4061，较上一交易日下跌1.35%，近一年上涨26.45%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061600019309.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002550","BK0239"],"gpt_icon":0},{"id":"2542557646","title":"肝素概念盘中拉升，千红制药涨6.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542557646","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542557646?lang=zh_cn&edition=full","pubTime":"2025-06-12 09:56","pubTimestamp":1749693380,"startTime":"0","endTime":"0","summary":"06月12日，肝素概念盘中拉升，截至09点56分，肝素概念整体指数上涨0.68%，报1023.250点。从个股上来看，该概念的成分股中，千红制药涨6.51%，健友股份、常山药业、海普瑞涨幅居前。从资金上来看，截止发稿，肝素概念主力净流入为-8339.19万，其中健友股份受到资金热捧，主力净流入924.19万；拉长时间线来看，该板块近20日主力资金净流入-12.56亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612095620977bda8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612095620977bda8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0046","BK0186","002550","603707","BK0239"],"gpt_icon":0},{"id":"2542576855","title":"熊去氧胆酸概念盘中拉升，千红制药涨3.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542576855","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542576855?lang=zh_cn&edition=full","pubTime":"2025-06-12 09:39","pubTimestamp":1749692356,"startTime":"0","endTime":"0","summary":"06月12日，熊去氧胆酸概念盘中拉升，截至09点39分，熊去氧胆酸概念整体指数上涨0.50%，报1222.310点。从个股上来看，该概念的成分股中，千红制药涨3.08%，新华制药、共同药业、人福医药涨幅居前。从资金上来看，截止发稿，熊去氧胆酸概念主力净流入为-6427.53万，其中人福医药受到资金热捧，主力净流入229.97万；拉长时间线来看，该板块近20日主力资金净流入-4.34亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612093916a7046070&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612093916a7046070&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600079","BK0012","BK0185","BK0070","BK0239","BK0096","BK0028","002550","BK0188"],"gpt_icon":0},{"id":"2542555849","title":"东吴证券：给予千红制药买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2542555849","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542555849?lang=zh_cn&edition=full","pubTime":"2025-06-12 07:25","pubTimestamp":1749684318,"startTime":"0","endTime":"0","summary":"东吴证券股份有限公司朱国广近期对千红制药进行研究并发布了研究报告《QHRD107 EHA数据点评：Ⅱa期初步数据优秀，临床进展顺利》，给予千红制药买入评级。　　急性髓系白血病耐药、复发常见，存在未被满足的临床需求。但随访结果和真实世界研究表明，绝大多数患者面临复发和耐药风险。复发患者亚组ORR为70.0%，cCR为45.0%；80mg剂量组ORR80%，cCR70.0%。最新盈利预测明细如下：该股最近90天内共有3家机构给出评级，买入评级2家，增持评级1家。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061200002692.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002550","601555"],"gpt_icon":0},{"id":"2542301817","title":"6月11日千红制药现1笔大宗交易 机构净卖出8409.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542301817","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542301817?lang=zh_cn&edition=full","pubTime":"2025-06-11 17:07","pubTimestamp":1749632862,"startTime":"0","endTime":"0","summary":"证券之星消息，6月11日千红制药发生大宗交易，交易数据如下：大宗交易成交价格8.76元，成交960万股，成交金额8409.6万元，买方营业部为华泰证券股份有限公司常州和平北路证券营业部，卖方营业部为机构专用。近三个月该股共发生1笔大宗交易，合计成交9.6万手。截至2025年6月11日收盘，千红制药报收于8.76元，下跌0.9%，换手率11.98%，成交量114.74万手，成交额9.92亿元。该股最近90天内共有3家机构给出评级，买入评级2家，增持评级1家。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061100025844.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002550"],"gpt_icon":0},{"id":"2542361421","title":"病毒检测概念盘中跳水，千红制药跌0.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542361421","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542361421?lang=zh_cn&edition=full","pubTime":"2025-06-10 13:32","pubTimestamp":1749533536,"startTime":"0","endTime":"0","summary":"06月10日，病毒检测概念盘中跳水，截至13点32分，病毒检测概念整体指数下跌1.01%，报962.600点。从个股上来看，该概念的成分股中，千红制药跌0.24%，安科生物、明德生物跌幅居前。从资金上来看，截止发稿，病毒检测概念主力净流入为-6914.75万，其中塞力医疗受到资金热捧，主力净流入1.97亿；拉长时间线来看，该板块近20日主力资金净流入-14.97亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506101332169515d897&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506101332169515d897&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603716","002550","BK0239","BK0250"],"gpt_icon":0},{"id":"2541810765","title":"每周股票复盘：千红制药（002550）日涨幅偏离值达7%，股东减持计划完成","url":"https://stock-news.laohu8.com/highlight/detail?id=2541810765","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541810765?lang=zh_cn&edition=full","pubTime":"2025-06-08 01:14","pubTimestamp":1749316454,"startTime":"0","endTime":"0","summary":"截至2025年6月6日收盘，千红制药报收于8.49元，较上周的7.76元上涨9.41%。本周，千红制药6月4日盘中最高价报9.38元，股价触及近一年最高点。截至2025年6月2日，减持计划期限届满并实施完成，通过集中竞价交易方式累计减持公司股份10387979股，占公司总股本比例0.8117%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060800000089.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002550"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1752265710258,"stockEarnings":[{"period":"1week","weight":0.0272},{"period":"1month","weight":0.0788},{"period":"3month","weight":0.6948},{"period":"6month","weight":0.6596},{"period":"1year","weight":0.7601},{"period":"ytd","weight":0.5499}],"compareEarnings":[{"period":"1week","weight":0.0109},{"period":"1month","weight":0.0317},{"period":"3month","weight":0.084},{"period":"6month","weight":0.1078},{"period":"1year","weight":0.1817},{"period":"ytd","weight":0.0473}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"常州千红生化制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"57296人(较上一季度增加2.99%)","perCapita":"16715股","listingDate":"2011-02-18","address":"江苏省常州市新北区云河路518号","registeredCapital":"127980万元","survey":"　　常州千红生化制药股份有限公司的主营业务是药品生产许可证范围内的冻干粉、冻干粉针剂(含抗肿瘤药)、小容量注射剂(非最终灭菌)、片剂、硬胶囊剂、颗粒剂、原料药的研发、生产和销售。公司的主要产品是胰激肽原酶系列、复方消化酶胶囊（Ⅱ）、门冬酰胺酶系列和弹性酶系列、肝素钠及低分子肝素类系列。","listedPrice":32},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"千红制药(002550)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供千红制药(002550)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"千红制药,002550,千红制药股票,千红制药股票老虎,千红制药股票老虎国际,千红制药行情,千红制药股票行情,千红制药股价,千红制药股市,千红制药股票价格,千红制药股票交易,千红制药股票购买,千红制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"千红制药(002550)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供千红制药(002550)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}